Hi, it’s Amber in Hong Kong. For many of us, drug labels can be impossible to decipher. A small change may help. But before I ...
Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.
The University of Oklahoma's $2.1 billion enterprise represents one of Oklahoma's greatest assets. Our impact is changing the lives of all Oklahomans, through scholarship, research and more. 30,000+ ...
First announced on December 12, the recall affects nearly 8,000 bottles of diphenhydramine hydrochloride, also known as ...